Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03081858
Recruitment Status : Recruiting
First Posted : March 16, 2017
Last Update Posted : June 12, 2018
Sponsor:
Collaborator:
Lipac Oncology LLC
Information provided by (Responsible Party):
TesoRx Pharma, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : June 2019